SkinBioTherapeutics (GB:SBTX) has released an update.
SkinBioTherapeutics PLC has reported a significant change in share ownership, with Optibiotix Health Plc’s voting rights crossing a threshold on August 7, 2024, resulting in a new total of 11.03% voting rights, which reflects a decrease from the previous notification of 12.94%. The event indicates a notable shift in control and could impact the company’s stock performance and investor decisions.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
